BPA for jynarque

Ended Awarded Last action

Contract number
36E79720A0007
Awardee
Awarding agency
Task orders
3 $153,442 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$153,442 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 1% used
$15,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Otsuka America Pharmaceutical Inc. was awarded a single-award Blanket Purchase Agreement (BPA) by the National Acquisition Center with a ceiling value of $15 million and an ultimate completion date of March 26, 2025. This BPA, established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), enables the Department of Veterans Affairs to procure Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The BPA includes pricing updates reflective of 2025 public law adjustments and was awarded on a firm-fixed-price basis without set-aside designations. The indefinite delivery vehicle structure allows VA facilities across multiple Veterans Integrated Service Networks to efficiently issue delivery orders as needed to support veterans' healthcare requirements.

The three task orders documented under this BPA demonstrate the operational scope of pharmaceutical delivery across geographically dispersed Veterans Integrated Service Networks. These calls, ranging from approximately $10,000 to $113,000 in individual value, were issued by VISN 1 and VISN 12 between April 2020 and October 2021 for tolvaptan deliveries to locations in Pittsburgh, Pennsylvania and Chelsea, Maine. The firm-fixed-price contract structure establishes predictable pricing for VA medical centers while the BPA mechanism streamlines procurement processes for this critical specialty medication. Through this indefinite delivery vehicle, Otsuka America Pharmaceutical Inc. provides consistent supply chain support for the VA's specialized pharmaceutical needs, ensuring veteran beneficiaries have access to treatments for complex renal and metabolic conditions across the Veterans Health Administration system.

Task orders

Task order Ordering agency Obligated Awarded
Medication 36C24121N0088 Veterans Integrated Service Network 1 (VHA) $113,304
Tolvaptan 36C24120N0812 Veterans Integrated Service Network 1 (VHA) $30,104
Tolvaptan 36C25220N0295 Veterans Integrated Service Network 12 (VHA) $10,035

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · 2025 public law pricing updates. $0
Exercise an Option P00009 · Exercise the 4TH and final option year $0
Supplemental Agreement for work within scope P00008 · 2024 public law updates $0
Exercise an Option P00007 $0
Supplemental Agreement for work within scope P00006 · 2023 public law updates $0
Exercise an Option P00005 · Exercise the 2ND option year $0
Supplemental Agreement for work within scope P00004 · 2022 public law updates $0
Exercise an Option P00003 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00002 · Product addition of 2 jynarque ndcs $0
Supplemental Agreement for work within scope P00001 · 2021 public law pricing updates $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36E79720A0007?

36E79720A0007 was awarded to Otsuka America Pharmaceutical Inc. by National Acquisition Center (Headquarters) on March 27, 2020.

How much is contract 36E79720A0007 worth?

Orders under 36E79720A0007 have obligated $153,442. 36E79720A0007's own ceiling is $15,000,000.

How many orders have been placed under contract 36E79720A0007?

3 orders have been placed under 36E79720A0007, the latest on October 15, 2020.

Who can order from contract 36E79720A0007?

36E79720A0007 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79720A0007 under another contract?

Yes. 36E79720A0007 is a blanket purchase agreement under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79720A0007 competed?

The extent of competition for 36E79720A0007 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV